SAV1 and non-small cell lung carcinoma: The antiproliferative activity of DBG (12 nM) was similar to that of GEF (1 μM) alone in the HCC827 cells and that of GEF and SAV coadministration in the HCC827GR cells, implying that DBG could serve as a chemotherapeutic agent in treating NSCLC.